Automated Slide Scanner
Closed Pre-Solicitation Posted
- Solicitation number
- 75N95024Q00405
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- Not on record
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH), is seeking capability statements from small businesses for an automated slide scanner system. The NINDS requires a slide scanner with specific features such as objectives, filters, camera, and software. The period of performance is anticipated to be 90 days after receipt of order. The government will use evaluation preferences for domestic sources in accordance with FAR 25 if a future solicitation is published. Interested companies must submit capability statements addressing the technical and administrative requirements by July 18, 2024.
This is a pre-solicitation notice and no set-aside designation has been provided. The government will use the information gathered to determine the availability of qualified sources, the method of acquisition, and the availability of domestic sources. No award will be made as a result of this notice, and the government will not be responsible for any costs incurred by respondents.
Notice text
The NINDS is a part of the National Institutes of Health (NIH), conducting research into the causes, treatment, and prevention of neurological disorders and stroke. The National Institute of Neurological Disorders and Stroke (NINDS) mission is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
Research in the Cellular Neurophysiology Section (CNS) in NINDS focuses on circuit and cellular properties of dopaminergic neurons located in the midbrain. We are interested in the physiology of a subset of dopamine neuron located in the substantia nigra pars compacta (SNc) that undergo selective cell death in Parkinson’s patients. Specifically, we are interested in understanding how synaptic and intrinsic conductances differ among subpopulations dopamine neurons with the hope that this may provide insight to why SNc dopamine neurons are particularly vulnerable in Parkinson’s disease. Our goal is to identify novel physiological and genetic markers in single SNc dopamine neurons which may be useful in defining subpopulations of these neurons in a meaningful way.
Files
| File | Type | Posted |
|---|---|---|
| B Sources Sought Notice.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Service agreement for the Nikon AXR-NSPARC confocal | Office of Logisitics and Acquisition Operations | No set-aside | |
| Service Maintenance for Leica Stellaris 8 SN 8300000509 | Office of Logisitics and Acquisition Operations | No set-aside | |
| Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity